df-mp Drries Frank-Molnia & Pohlman Patentanwlte Rechtsanwlte PartG mbB, filed apatent infringement counterclaim against Illumina, https://policies.google.com/privacy?hl=en, https://www.hotjar.com/legal/policies/privacy/, https://www.facebook.com/privacy/explanation, https://policies.google.com/privacy?hl=en&gl=en, https://wiki.osmfoundation.org/wiki/Privacy_Policy. Analysts say the bad news is prompting investors to question the company's strategy of buying Grail, which Illumina forecasts will generate an operating loss of $670mn in 2023 on revenues of. According to MGIs statement:The parties also agree to a three-year period of peace with respect to claims of U.S. patent infringement and violations of any antitrust or unfair competition laws of the United States, during which time they will not sue each other or respective customers in the United States or accrue liability for existing platforms.. You can find more information about the use of your data in our privacy policy. The case is Complete Genomics Inc. v. Illumina Inc., D. User-provided information. The companies have a history of heated courtroom clashes. So one option they have is to push pricing as low as they can and have slightly better data quality (lets say, maxing out read length at 300bp as opposed to competitors being at ~100bp and having 90% >Q30 versus say 70%). All quotes delayed a minimum of 15 minutes. Complete Genomics is represented by Young Conaway Stargatt & Taylor LLP and Quinn Emanuel. Statistics cookies collect information anonymously. For cost savings, you can change your plan at any time online in the Settings & Account section. 2020 preliminary results: Illumina said it finished last year with about $4.517 billion in revenue, up 39% from 2020, including about $1.19 billion in fourth-quarter revenue, up 25% over. The DNA sequencing patents are interesting for competitors such as MGI and the BGI Group, which are also in the . Law360, San Francisco (November 30, 2021, 11:16 PM EST) -- A California federal jury determined Tuesday that four out of five of Illumina 's patents behind its next-generation genome-sequencing . Then everyone buys Illumina sequencers because they have the lowest cost and highest quality! This information helps us to understand how our visitors use our website. The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs. Get ready for your week with the weeks top business stories from San Diego and California, in your inbox Monday mornings. 258 0 obj <>stream Please umount/remount instead, LTC1859 8 Channel, 100KSPS +/- 10V 16bit ADC Arduino Shield layout, AD5791 20Bit DAC Evaluation board with Arduino, LTC1859CG Evaluation board with an Arduino, Cheap Z-stage (SELN LZ-60 Shengling Precise Machinery CO. Ltd), Fractal Slippy Map in golang and LeafletJS, Serving server generated PNGs over HTTP in golang, Kindlegen, W14001: Hyperlink not resolved errors, hp t5325 thin client information and manuals, HY-DIV268N-5A Stepper driver with Arduino, Most common git screwups/questions and solutions, Select random line from a file in a single pass, Serving gziped connect via HTTP in golang, USRP1 simple data capture in C++ example (UHD), Some simple Arduino code to read from a keypad, Using the Arduino tools from the Linux command line, Simple JS->DNS Proxy with golang server side, MSP430Watch2 Barometer and Wifi (PCB Design), Creating an SVG in Javascript using FabricJS and downloading it locally, Creating an SVG in Javascript, trivial example, Kicad Gerber renaming script for OSHPark (and seeed etc) submission, Anritsu MT8815b Radio Communication Analyzer Notes, esp8266 writing to internal flash (basic key/value store), Accepting incoming tcp connections on the esp8266 (trivial example), A standalone sscanf implementation (for the esp8266), Installing Nagios on Debian Jessie and SNMP (UPS) monitoring, Posting to the Safecast API from the esp8266, esp8266 client mode (connect to remote host) simple example, Gorilla Websockets, golang simple websockets example, Getting to awa-kamogawa from Tokyo by train, Emscripten calling JS from C and returning by reference (pointer), Calling JS from C using EM_ASM in Emscripten, Compiling OpenSSL and libssh2 with emscripten notes, Sony/Tektronix 3066 DC-3GHz Realtime spectrum analyzer, Astable multivibrator RGB flasher PCB design, A Common Emitter Hartley Oscillator Notes, Logitec LBT-VRU01 (bluetooth LE iPhone locator? Probability of choosing at least one target, Ubuntu 20.04 Fujitsu FAREHT1 Mouse/Touch Screen Fixes, Beckman DU530 Spectrophotometer CFL Spectra, Beckman DU530 Photospectrometer (Hach DR4000?) Personal data may be processed (e.g. Additional patent lawsuits have been filed in Denmark, Finland, Germany, Sweden, Switzerland, Turkey and the United Kingdom. Illumina virtual patent marking The following Illumina products may be covered by one or more patents as indicated below Notice is hereby provided under 35 U.S.C. In addition, the EPO revoked patents EP 2 338 893 and EP 1 451 351 B1from a patent family for labelled nucleotides. This is the first time the UK patent courts have truly grappled with sufficiency at a lower instance. Each company sought a reasonable royalty for the alleged infringement of its patents by certain features of the accused products. Illumina is forking over the $325 million to settle claims following two recent jury decisions in Delaware and California, as well as an antitrust case in California, according to a statement on Thursday from MGI Tech, a BGI affiliate. Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.Youll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. An Illumina spokesperson said the company plans to appeal and that the verdict should not affect its ability to supply its customers. Well, I expect prices to do down, but I wouldnt expect Illumina to solely compete on price. 10,480,025 (the '025 Patent) asserted against BGI in the suit, which are directed to blocked and other data for a number of reasons, such as keeping FT Sites reliable and secure, But I think whats really more interesting to me are approaches that reduce the COGS. The companies have been embroiled in a global legal battle over their respective sequencing technologies, with court cases in countries including Germany, Denmark, Switzerland, and Turkey. Please see our Privacy Policy. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Orrick denied Illumina's motions for attorneys' fees and enhanced damages but upheld a finding of willful infringement and awarded Illumina prejudgment interest at the prime lending rate, compounded quarterly. In July 2019, Illumina filed counterclaims alleging certain models of the BGISEQ and MGISEQ genetic sequencing instruments infringe three Illumina patents. The listed products and their use are the subject of the following US Patent Nos. Already a subscriber? We use We use cookies and other technologies on our website. Hide Cookie Information. Theyre iterated over the original IP pretty well and have a number of other advantages over new players specifically: This is all technology was developed for Hiseqs and later instruments. Well, for a start I expect it to put downward pressure on Illuminas consumable pricing. Any changes made can be done at any time and will become effective at the end of the trial period, allowing you to retain full access for 4 weeks, even if you downgrade or cancel. 7,375,234; 7,763,736; 8,129,542; 8,580,970; 8,877,939 and related patents and patent applications. Del., 19-cv-970), Jury also cancels three patents from Illuminas counterclaims, BGI infringement of two Illumina patents mooted by voiding. Save Standard Digital includes access to a wealth of global news, analysis and expert opinion. If youd like to retain your premium access and save 20%, you can opt to pay annually at the end of the trial. In late March, a federal judge in San Francisco upheld a jurys November verdict awarding Illumina $8 million for BGI Genomics infringement of at least one valid claim in three of the five genetic-sequencing patents at issue. Hotjar is an user behavior analytic tool by Hotjar Ltd.. We use Hotjar to understand how users interact with our website. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Patents. 6 February 2023 Except Illumina dont make much money that way. And I suspect is why theyre shopping around for acquisitions. Some of them are essential, while others help us to improve this website and your experience. Mathys & Squire (London): Philippa Griffin, Strawman The European Patent Office has destroyed several patents belonging to Illumina, a US manufacturer of genetic engineering equipment. You have to know whats happening with clients, competitors, practice areas, and industries. Illumina's shares dropped sharply following the verdict but have rebounded somewhat since. The listed products and their use are the subject of US Patent Nos. 10,480,025, titled "Labelled nucleotides"while . Illumina Inc. owes BGI Group, the worlds largest maker of commercial genetic sequencers, $333.8 million after a federal jury in Delaware found Friday that some of its DNA sequencing systems infringe two patents related to technology that deduces each nucleotides identity from two signals. hb```v eah`hje0sDt'j;:*:::$ np4p&~P%CH@| .Hibe`1Fq10f@$` !1 During your trial you will have complete digital access to FT.com with everything in both of our Standard Digital and Premium Digital packages. In June 2019, Illumina filed the first lawsuit against BGI in the US, alleging that the Chinese company's sequencing technology infringed its own sequencing-by-synthesis chemistry, specifically US Patent Nos. In particular its been disappointing to see the limited impact of sequencing on SARS-CoV2 diagnostics. This website uses cookies so that we can provide you with the best user experience possible. Simmons + Simmons LLP. One is estimated to expire in December 2025, another in January 2026the jury found BGIs products infringe those twoand a third in February 2026. Whats your favorite San Diego County beach? cookies The Biden administration is close to tightening rules on some overseas investments by American companies, A Volkswagen Group-backed automotive company announced plans this week to open a $2 billion electric truck and SUV manufacturing plant just outside of Columbia, South Carolina, Oklahoma voters are deciding whether to legalize marijuana sales for those 21 and older. The jury's verdict follows the decision of Judge William Orrick, in the same case, to award Illumina summary judgment on claims of infringement by BGI's StandardMPS and CoolMPS products. At the low end is a $20,000 desktop sequencer that put sequencing within reach of more scientists. ), Create custom alerts for specific article and case topics and, I took a free trial but didn't get a verification email. My name is Nava Whiteford. In April, Illumina won an $8 million verdict against BGI from a jury in Northern California federal court, as well as a permanent injunction. Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. Complete Genomics filed the suit in May 2019, claiming San Diego-based Illuminas two-channel DNA sequencing systems infringe a patent for the technology, which deduces the identity of each nucleotide from two signals. SAN DIEGO-- (BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) today announced that the High Court of Justice, Chancery Division, Patents Court, issued a judgment in its favor in the patent infringement suit filed against the BGI Companies, MGI Tech Co. Ltd; Latvia MGI SIA; MGI International Sales Co., Ltd; and BGI Complete Genomics Hong Kong Co., Limited Use Label License: This product and its use are the subject of one or more issued and/or pending US and foreign patent applications owned by Max Planck Gesellschaft, exclusively licensed to New England Biolabs, Inc. and sublicensed to Illumina, Inc. But my understanding is that the 9N (9 degrees North) and related polymerases incorporate modified nucleotides pretty well. In the Delaware case, San Jose, California-based Complete Genomics Inc, a BGI subsidiary, had challenged Illumina's "two-channel" sequencing systems and kits to prepare DNA fragments for sequencing of violating its patent rights. He said the company is also pleased that the jury invalidated the cases three Illumina patents. Cookie by Google used to control advanced script and event handling. Privacy Policy 9,085,798; 9,783,847; 10,000,800 and related patents and patent applications. Judge William H. Orricks March 27 order in the U.S. District Court for the Northern District of California resolved a spate of issues in two suits between the rivals, including by its denial of BGIs bid for a new trial. The stock closed Friday up 7.4 percent at $233.56 on the Nasdaq exchange. Ive looked at most of these. But in May, a Delaware jury decided that Illumina owes Complete Genomics more than $333 million for infringing on two patents, court documents state. (Updates May 6 story with comment from MGI in seventh paragraph and adds additional details throughout on BGI's corporate structure. In this case, the jury found Illumina willfully infringed on BGI/Complete Genomics patents related to two-channel techniques used in genomics sequencing. So if youd be interest in investing in (or codeveloping) such a platform, get in touch. Law360 provides the intelligence you need to remain an expert and beat the competition. | Tesla recalls 3,470 Model Y vehicles over loose bolts, Exclusive: Nvidia's plans for sales to Huawei imperiled if U.S. tightens Huawei curbs-draft, Reporting by Blake Brittain in Washington; additional reporting by Raghavi Kasa; Editing by David Gregorio and Diane Craft, Mexico can't match U.S. incentives for proposed Tesla battery plant, minister says, Taiwan's TSMC to recruit 6,000 engineers in 2023, Twitter's revenue, adjusted earnings drop about 40% in December - WSJ, Exclusive news, data and analytics for financial market professionals. They do this by tracking visitors across websites. The Singular platform looks like this to me, probably using alternate nucleotides until 2024 that is if they actually launch before 2024. Great! The patents cover Illumina's proprietary sequencing-by-synthesis chemistry. university Premium access for businesses and educational institutions. The purchase of this product from Illumina, Inc., its affiliates, or its authorized resellers and distributors conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product by the buyer (whether the buyer is an academic or for-profit entity). DNA Sequencing is Universal Sensing, Mitutoyo Digimatic 500-133U CDL-6B Battery Cover Model, NEC Teledata Terminal Shop Register (TD7), Motorboard Easydriver/Arduino/PKE243DA interface r1, Veeco Nanoscope V Multimode AFM First Imaging Tests, Axopatch 200A with micropipette first tests, Playing with a micropipette puller (Sutter P-97), Couldnt remount RDWR because of unprocessed orphan inode list. This broadening of the market sucks for Illumina. As a result, companies are now fighting hard for market share in this cutting-edge technology. We use cookies and other technologies on our website. Premium Digital includes access to our premier business column, Lex, as well as 15 curated newsletters covering key business themes with original, in-depth reporting. For specific trademark information, see www.illumina.com/company/legal.html. Analysis, Biological Data original cluster generation IP has expired (from Manteia) has expired. In a later Delaware case, Complete Genomics accused Illumina of infringing on its own patents with two-channel sequencing systems, kits to prepare DNA fragments for sequencing and kits to immobilize, amplify and sequence fragments. You may occasionally receive promotional content from the San Diego Union-Tribune. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. travels to Asia to strengthen business ties, How major US stock indexes fared Friday 3/3/2023, VMware, Broadcom rise; Marvell, Bumble fall. Retailer Reg: 2019--2018 | The jury also said Illumina infringed the patents willfully, and that three patents it had accused BGI's Complete Genomics unit of infringing were invalid. The European Patent Office has destroyed several patents belonging to Illumina, a US manufacturer of genetic engineering equipment. 7,541,444 (the '444 Patent) and U.S. Patent No. For the global patent community. We use cookies on our website. Illumina Pays To Settle Years-Long Patent Battles, Investors Withdraw $6B From Binance Amid Crypto Regulation, Meta Offers New Options For Researchers Working In Artificial Intelligence, Microsoft, Activision Deal Review Extended By The European Commission, Microsoft Drastically Scales Back Metaverse Project, Focuses On AI, Bill That Aims To Block TikTok Approved By US House Panel, EU: Google promotes rivals to stave off antitrust action. It is Illumina's policy to seek patent protection in the United States and abroad for such technology and products. I therefore would expect at the very least for genome analyzer 2 style instruments to start appearing. (This story corrects statement in paragraph 1 that Complete Genomics is a subsidiary of BGI Genomics to reflect that it is part of BGI Group). Systems and methods for biochemical analysis including a base instrument and a removable cartridge, Methods and compositions for whole genome amplification and genotyping, BASE CALLING USING THREE-DIMENTIONAL (3D) CONVOLUTION, DEEP LEARNING-BASED SPLICE SITE CLASSIFICATION, Compositions for use in polynucleotide sequencing, LAMINATE FLUIDIC CIRCUIT FOR A FLUID CARTRIDGE, DEEP NEURAL NETWORK-BASED VARIANT PATHOGENICITY PREDICTION, POLYMERASES, COMPOSITIONS, AND METHODS OF USE, Charge-tagged nucleotides and methods of use thereof, Photonic structure-based devices and compositions for use in luminescent imaging of multiple sites within a pixel, and methods of using the same, Flowcell cartridge with floating seal bracket, SEMICONDUCTOR-BASED BIOSENSORS FOR BASE CALLING, BASE CALLING USING MULTIPLE BASE CALLER MODELS, DEEP LEARNING-BASED USE OF PROTEIN CONTACT MAPS FOR VARIANT PATHOGENICITY PREDICTION, TRANSFER LEARNING-BASED USE OF PROTEIN CONTACT MAPS FOR VARIANT PATHOGENICITY PREDICTION, QUALITY SCORE CALIBRATION OF BASECALLING SYSTEMS. 287 (a) for the following products: Last Updated: 2022-06-23 No one on our HOA board has been elected and they all remain on by default year after year. So the cluster and nucleotide IP are really the key to producing an Illumina-style DNA sequencer. We do not anticipate that this decision will affect our ability to supply and service our customers.. Want more news? The stock closed Friday up 7.4. This week, the EPO Boards of Appeal rejected Illuminas appeal concerningEP 2 325 304(T2248/14-3.3.08), resulting in the loss of the patent. ), Illumina Win Over BGI Upheld as Judge Blocks Gene Sequencers (2), Illumina, BGI Trim Patent Claims as Another Jury Trial Looms, BGI Asks For New Patent Trial After $8 Million Loss to Illumina, BGI Must Pay Illumina $8 Million in Gene-Sequencing Patent Spat, Complete Genomics Inc. v. Illumina Inc. (D. IP addresses), for example for personalized ads and content or ad and content measurement. Cookie Details Reach him at blake.brittain@thomsonreuters.com. You can contact me at: [emailprotected]. Q. Analysts say the bad news is prompting investors to question the company's strategy of buying Grail, which Illumina forecasts will generate an operating loss of $670mn in 2023 on revenues of. Privacy Policy Ive worked for a few sequencing companies. Illumina invented its 2-channel technology before the BGI patents, and BGI was unable to make 2-channel chemistry work until it copied Illuminas technology, the spokesperson said in a statement. I figured Id summarize my thoughts here. _hjClosedSurveyInvites, _hjDonePolls, _hjMinimizedPolls, _hjDoneTestersWidgets, _hjIncludedInSample, _hjShownFeedbackMessage, _hjid, _hjRecordingLastActivity, hjTLDTest, _hjUserAttributesHash, _hjCachedUserAttributes, _hjLocalStorageTest, _hjptid, Meta Platforms Ireland Limited, 4 Grand Canal Square, Dublin 2, Ireland, Openstreetmap Foundation, St Johns Innovation Centre, Cowley Road, Cambridge CB4 0WS, United Kingdom, _osm_location, _osm_session, _osm_totp_token, _osm_welcome, _pk_id., _pk_ref., _pk_ses., qos_token, Twitter International Company, One Cumberland Place, Fenian Street, Dublin 2, D02 AX07, Ireland, __widgetsettings, local_storage_support_test, Vimeo Inc., 555 West 18th Street, New York, New York 10011, USA. organisation Simply log into Settings & Account and select "Cancel" on the right-hand side. It also targeted Illuminas library preparation kits and cluster generation and sequencing kits compatible with one or more of the systems, according to court papers. As part of the deal, each party will drop any challenges to the California and Delaware jury decisions, and Illumina gets a license to the family of patents that BGI asserted in Delaware. Host: https://www.illumina.com | But they probably wont be the only player to take this approach. But how else will they respond? And I suspect companies like Element are working on something similar. personalising content and ads, providing social media features and to IP addresses), for example for personalized ads and content or ad and content measurement. David Bilsker, a lawyer from Quinn Emanuel Urquhart & Sullivan LLP who represented Complete Genomics, said the jurys findings shows the strength of Rade Drmanacs inventions. N choose K, with T targets. In 2010, Illumina filed a complaint in California against Complete Genomics, an MGI subsidiary, alleging that the company infringed on three of its DNA sequencing patents with the latter companys Complete Genomics Analysis Platform. In response, Complete Genomics asserted that Illumina had attempted to achieve monopoly power in genome sequencing technology.. Essentially for everything else available or on the horizon the data quality is not as good and COGS is higher than the Illumina approach. The latest of these patents is due to expire in 2024. Essential cookies enable basic functions and are necessary for the proper function of the website. While Illumina claims that BGI and its subsidiaries willfully infringed five of its patents related to its DNA sequencing technology and is entitled to $25 million in damages, BGI says the. An Illumina spokesperson said the company disagrees with the verdict and plans to appeal. From Europe. Illumina MiSeq Dx Cystic Fibrosis Assays, TruSeq Stranded total RNA Sample Prep Kits, BaseSpace Cohort Analyzer Related Products, BaseSpace Variant Interpreter Related Products, BaseSpace Correlation Engine Related Products. 6,730,777 and 6,984,487 licensed from The Regents of the University of Michigan and the HSC Research Development Limited Partnership. In July 2020, Complete Genomics amended its complaint to add a patent that had been issued that May and covers the same technology. The European patent attorney also regularly files patents for the US company at theEPO. Filed under Sequencing Business News Asia/Oceania lawsuit North America Illumina is constantly conducting research and development, leading to new, modified, and/or improved technology and products. Photodiode Amplifier Board, Photobeaching on the Genome Analyzer, using a IMX178, Single Dye Experiments on a Genome Analyzer, Genome Analyzer Quantum GEM 532nm Laser and filters. The patent covers a DNA sequencing method. 7,541,444, titled "Modified nucleotides," and claim 1 of U.S. Patent No. For Illumina A spokesperson for MGI Tech Co., which owns Complete Genomics, said MGI is pleased with verdict. The company also filed an anticompetitive suit against Illumina in Delaware last year. As I understand it with that IP alone you could make something that looks very much like a genome analyzer 2. Illumina's stock was down more than 14% Friday following the verdict. 287(a) for the following products: Infrastructure It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Many of the cases have settled, though some remain under appeal. The nearly $1 million Novaseq 6000 is expected to one day unlock the $100 genome. We use cookies and other technologies on our website. Can Shell close the valuation gap with US rivals? Not for import or sale to the Australian general public. If External Media cookies are accepted, access to those contents no longer requires manual consent. Im not a patent lawyer, so you should consider that when evaluating my thoughts. The costs of this technology have fallen sharply in recent years. Compare Standard and Premium Digital here. See here for a complete list of exchanges and delays. According to an exhibitfiled with the complaint, Illumina said a BioRxivpreprintposted Feb. 20 proved CoolMPS technology infringed the '973 patent. According to Illumina, the '444 patent was set to expire in June 2023 and US Patent No. Show Cookie Information The jury, which started deliberating Thursday afternoon, also found that sequencers sold by BGIs Complete Genomics Inc. infringe two of three Illumina patents, but it said all three shouldnt have been issued in the first place, mooting any potential award, according to the verdict issued in the U.S. District Court for the District of Delaware. Illumina, or (ii) any expiration date or the end of the shelf-life pre-printed on the consumable, but in either event, no later than 12 months from the date of shipment. An Encoding And Correction Approach for DNA Data Storage, Using an SBS-like approach to selectively amplify, Reprogramming a ATTINY85 to use an external oscillator using the Arduino IDE, Nanopore DNA Sequencing Research Groups (August 2018), DNA Sequencing Companies (Updated May 2020), Inheco Control 96 + CPAC Ultraflat Notes (TEC/Peltier), Veeco/Bruker AFM (nanosope) head teardown pics, uMD1 ChipKIT 32 HP Interferometer Interface, Penrose Puzzle Lessons Learned from Rev 0, Embedding Electronics in Transparent Resin, Another iPhone MEMS Mic (different configuration+layers), Throwing the BME280 Combined Pressure/Humidity Sensor in a SEM, MXq Quad Core Android Thoughts (and console kernel messages), 11inch Celestron CPC Series Telescope Repair Initial Photos, A Brief Computational Analysis of Pen-Pineapple Apple-pen, esp32 USB Stick (esp32 + ch340g + buck conv + sd card), FG-100 Soldering Iron Tip Temperature Sensor, Fiddling with a cheap 5 port dumb switch to add VLANs/port mirroring, Marking intervals in gnuplot graph (with shading), awk print text between 2 identical markers in a file, A git pre-commit hook to do SVN style $Date$ substitution, Sony WPSD5 Surround Sound System repair Notes, Interfacing Hitachi HD44780 LCDs using I2C on an Arduino, Notes on Genias new paper nanopore SBS, Are you sure this isnt horse? Try full digital access and see why over 1 million readers subscribe to the FT, Purchase a Trial subscription for $1 for 4 weeks, You will be billed $69 per month after the trial ends, Russian far-right fighter claims border stunt exposes Putins weakness, Something is boiling: Turkish football fans tackle Erdoan, Three-day weekends and more time for love: Chinas elite dream up policies for Xi, Germany and Italy stall EU ban on combustion engines, Feds Daly says US rates likely to be higher for longer, Saudi owner of Londons most expensive house sued over alleged unpaid private jet bills, Why the Jeffrey Epstein scandal continues to haunt JPMorgan and Barclays, US electric vehicle batteries poised for new lithium iron age.